Barney, J
"Across five positive Phase 3 studies, retatrutide has shown powerful efficacy, and we believe it could be an important future tool in the management of cardiometabolic health," said Kenneth Custer, Ph.D., executive vice president and president, Lilly Cardiometabolic Health
Contact Us Give us a call (629) 278-2163 We're Just a Message Away Whether you have questions about our services, need assistance with scheduling an appointment, or want to learn more about how we can support your health needs, our team is here to help
Cada pedido incluye COA por lote y envo a todo Mxico
2 In the 72-week ATTAIN-1 trial, adults without diabetes who took the highest dose of Foundayo achieved an average weight loss of 27.3 pounds (12.4%), compared to 2.2 pounds (0.9%) in the placebo group
In our clinic, Semaglutide GLP-1 supports weight loss by reducing appetite, slowing gastric emptying, and enhancing the feeling of fullness